Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic phenotypes of early-stage lung adenocarcinoma.

The European respiratory journal - 1 Jul 2022

Lamort Anne-Sophie, Kaiser Jan Christian, Pepe Mario A A, Lilis Ioannis, Ntaliarda Giannoula, Somogyi Kalman, Spella Magda, Behrend Sabine J, Giotopoulou Georgia A, Kujawa Willem, Lindner Michael, Koch Ina, Hatz Rudolf A, Behr Juergen, Sotillo Rocio, Schamberger Andrea C, Stathopoulos Georgios T

Abstract excerpt

BACKGROUND: Survival after curative resection of early-stage lung adenocarcinoma (LUAD) varies and prognostic biomarkers are urgently needed. METHODS: Large-format tissue samples from a prospective cohort of 200 patients with resected LUAD were immunophenotyped for cancer hallmarks TP53, NF1, CD45, PD-1, PCNA, TUNEL and FVIII, and were followed for a median of 2.34 (95% CI 1.71-3.49) years. RESULTS: Unsupervised...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma of Lung
Share to Lung Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Prognosis

Share to Proliferating Cell Nuclear Antigen

Source

Identifiers

PMID: 34887322
DOI: 10.1183/13993003.01674-2021

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic phenotypes of early-stage lung adenocarcinoma.PMID 34887322Read ↗

Cancer Essential Genes Stratified Lung Adenocarcinoma Patients with Distinct Survival Outcomes and Identified a Subgroup from the Terminal Respiratory Unit Type with Different Proliferative Signatures in Multiple CohortsSemantic proximity Read ↗

Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations.Semantic proximity Read ↗

Highly proliferating cancer cells function as novel prognostic biomarkers for lung adenocarcinoma with particular usefulness for stage IA risk stratification.Semantic proximity Read ↗

Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patternsSemantic proximity Read ↗

The new histologic classification of lung primary adenocarcinoma subtypes is a reliable prognostic marker and identifies tumors with different mutation status: the experience of a French cohort.Semantic proximity Read ↗

Simplified Molecular Classification of Lung Adenocarcinomas Based on EGFR, KRAS, and TP53 MutationsSemantic proximity Read ↗

EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype.Semantic proximity Read ↗

An Aggressive Subtype of Stage I Lung Adenocarcinoma with Molecular and Prognostic Characteristics Typical of Advanced Lung Cancers.Semantic proximity Read ↗

Prognostic and Chemotherapy Predictive Value of Gene-Expression Phenotypes in Primary Lung Adenocarcinoma.Semantic proximity Read ↗

A prognostic signature for lung adenocarcinoma in people who have never smokedSemantic proximity Read ↗

Clinical, Pathologic, and Molecular Prognostic Factors in Patients with Early-Stage EGFR-Mutant NSCLC.Semantic proximity Read ↗

The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.